| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $1,253,734 ) |
| | 2026 | 2026 | TRUDEAU INSTITUTE INC | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI194706 | Probing the novel mechanism of action of tuberculocidal compounds | 000 | 1 | NIH | 2/8/2026 | $332,414 |
| | 2026 | 2026 | TRUDEAU INSTITUTE INC | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R01AI195815 | Optimization of Antitubercular Compounds Against a Novel Mycobacterium tuberculosis target, AspC | 000 | 1 | NIH | 1/28/2026 | $921,320 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | TRUDEAU INSTITUTE INC | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI159731 | Development of a mouse model of tuberculosis that generates human-like pathology | 000 | 2 | NIH | 9/17/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $247,500 ) |
| | 2023 | 2023 | TRUDEAU INSTITUTE INC | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI159731 | Development of a mouse model of tuberculosis that generates human-like pathology | 000 | 2 | NIH | 2/22/2023 | $247,500 |
| | 2023 | 2021 | TRUDEAU INSTITUTE INC | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI144386 | A novel drug retargeting platform for drug-resistant bacterial infections | 000 | 2 | NIH | 6/23/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $297,000 ) |
| | 2022 | 2022 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI159731 | Development of a mouse model of tuberculosis that generates human-like pathology | 000 | 1 | NIH | 2/23/2022 | $297,000 |
|
| Issue Date FY: 2021 ( Subtotal = $247,500 ) |
| | 2021 | 2021 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI144386 | A novel drug retargeting platform for drug-resistant bacterial infections | 000 | 2 | NIH | 12/18/2020 | $247,500 |
| | 2021 | 2020 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R03AI144706 | Inhaled DNase as an Adjunctive Tuberculosis Therapy | 000 | 2 | NIH | 9/9/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $396,000 ) |
| | 2020 | 2020 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI144386 | A novel drug retargeting platform for drug-resistant bacterial infections | 000 | 1 | NIH | 1/21/2020 | $297,000 |
| | 2020 | 2020 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R03AI144706 | Inhaled DNase as an Adjunctive Tuberculosis Therapy | 000 | 2 | NIH | 1/10/2020 | $99,000 |
| | 2020 | 2018 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AG054973 | An improved mouse model for aging immunology | 000 | 2 | NIH | 5/18/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $99,000 ) |
| | 2019 | 2019 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R03AI144706 | Inhaled DNase as an Adjunctive Tuberculosis Therapy | 000 | 1 | NIH | 2/8/2019 | $99,000 |
|
| Issue Date FY: 2018 ( Subtotal = $297,861 ) |
| | 2018 | 2018 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AG054973 | An improved mouse model for aging immunology | 002 | 2 | NIH | 8/31/2018 | $50,361 |
| | 2018 | 2018 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AG054973 | An improved mouse model for aging immunology | 000 | 2 | NIH | 3/8/2018 | $222,750 |
| | 2018 | 2018 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AG054973 | An improved mouse model for aging immunology | 001 | 2 | NIH | 4/13/2018 | $24,750 |
|
| Issue Date FY: 2017 ( Subtotal = -$94,959 ) |
| | 2017 | 2017 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AG054973 | An improved mouse model for aging immunology | 000 | 1 | NIH | 3/3/2017 | $297,000 |
| | 2017 | 2016 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI111000 | Defining the role of lymphotoxin signaling in viral-induced lung immunopathology | 002 | 2 | NIH | 3/31/2017 | $0 |
| | 2017 | 2016 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI111000 | Defining the role of lymphotoxin signaling in viral-induced lung immunopathology | 001 | 2 | NIH | 1/2/2017 | -$215,699 |
| | 2017 | 2015 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | T32AI049823 | Research Training in Immunology and Infectious Diseases | 000 | 15 | NIH | 2/10/2017 | -$146,232 |
| | 2017 | 2015 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R01AG039485 | Aging, T cell repertoire, and cellular immunity to influenza virus | 000 | 5 | NIH | 11/23/2016 | $0 |
| | 2017 | 2015 | TRUDEAU INSTITUTE, INC. | 154 ALGONQUIN AVE | SARANAC LAKE | NY | 12983-2100 | FRANKLIN | USA | R21AI113517 | Targeted Nanoparticle Vaccine Approach for Protection Against Encapsulated Pathogens | 000 | 1 | NIH | 4/10/2017 | -$30,028 |
|
| Issue Date FY: 2016 ( Subtotal = $5,850 ) |
| | 2016 | 2016 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R21AI111000 | Defining the role of lymphotoxin signaling in viral-induced lung immunopathology | 000 | 2 | NIH | 12/21/2015 | $243,750 |
| | 2016 | 2016 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R21AI111000 | Defining the role of lymphotoxin signaling in viral-induced lung immunopathology | 001 | 2 | NIH | 5/4/2016 | -$243,750 |
| | 2016 | 2016 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R21AI111000 | Defining the role of lymphotoxin signaling in viral-induced lung immunopathology | 001 | 2 | NIH | 5/4/2016 | $243,750 |
| | 2016 | 2015 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R21AI113517 | Targeted Nanoparticle Vaccine Approach for Protection Against Encapsulated Pathogens | 000 | 1 | NIH | 1/26/2016 | -$237,900 |
|
| Issue Date FY: 2015 ( Subtotal = $951,992 ) |
| | 2015 | 2015 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | T32AI049823 | Research Training in Immunology and Infectious Diseases | 000 | 15 | NIH | 4/22/2015 | $173,113 |
| | 2015 | 2015 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R21AI113517 | Targeted Nanoparticle Vaccine Approach for Protection Against Encapsulated Pathogens | 000 | 1 | NIH | 4/8/2015 | $292,500 |
| | 2015 | 2015 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R01AG039485 | Aging, T cell repertoire, and cellular immunity to influenza virus | 000 | 5 | NIH | 5/18/2015 | $193,879 |
| | 2015 | 2015 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R21AI111000 | Defining the role of lymphotoxin signaling in viral-induced lung immunopathology | 000 | 1 | NIH | 1/12/2015 | $292,500 |
|
| Issue Date FY: 2014 ( Subtotal = $591,275 ) |
| | 2014 | 2014 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R01AG039485 | Aging, T cell repertoire, and cellular immunity to influenza virus | 000 | 4 | NIH | 5/15/2014 | $199,875 |
| | 2014 | 2014 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R56AI104788 | iNKT and B Cell Cooperation in Immunity and Host Defense | 000 | 1 | NIH | 3/31/2014 | $243,750 |
| | 2014 | 2014 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R13AI109944 | The Yin and Yang of Inflammation | 000 | 1 | NIH | 2/28/2014 | $6,000 |
| | 2014 | 2014 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | T32AI049823 | Research Training in Immunology and Infectious Diseases | 000 | 14 | NIH | 4/18/2014 | $141,650 |
|
| Issue Date FY: 2013 ( Subtotal = $809,454 ) |
| | 2013 | 2013 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R01AI061577 | CELL-MEDIATED PROTECTION AGAINST PNEUMONIC PLAGUE | 001 | 9 | NIH | 6/5/2013 | $19,445 |
| | 2013 | 2013 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | T32AI049823 | Research Training in Immunology and Infectious Diseases | 000 | 13 | NIH | 5/22/2013 | $163,639 |
| | 2013 | 2013 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R01AI061577 | CELL-MEDIATED PROTECTION AGAINST PNEUMONIC PLAGUE | 000 | 9 | NIH | 1/24/2013 | $437,489 |
| | 2013 | 2013 | TRUDEAU INSTITUTE | ALGONQUIN AVENUE | SARANAC LAKE | NY | 12983 | FRANKLIN | USA | R01AG039485 | Aging, T cell repertoire, and cellular immunity to influenza virus | 000 | 3 | NIH | 5/22/2013 | $188,881 |
|
|
